Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

miR-126 regulates angiogenic signaling and vascular integrity.

Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D.

Dev Cell. 2008 Aug;15(2):272-84. doi: 10.1016/j.devcel.2008.07.008.

2.

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis.

Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN.

Dev Cell. 2008 Aug;15(2):261-71. doi: 10.1016/j.devcel.2008.07.002.

3.

Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells.

Chen C, Chai H, Wang X, Jiang J, Jamaluddin MS, Liao D, Zhang Y, Wang H, Bharadwaj U, Zhang S, Li M, Lin P, Yao Q.

Blood. 2008 Oct 15;112(8):3205-16. doi: 10.1182/blood-2008-03-143479. Epub 2008 Jul 24.

4.

MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression.

Lee DY, Deng Z, Wang CH, Yang BB.

Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20350-5. Epub 2007 Dec 11.

5.

Interfering with disease: a progress report on siRNA-based therapeutics.

de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J.

Nat Rev Drug Discov. 2007 Jun;6(6):443-53. Review.

PMID:
17541417
6.

Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis.

Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S.

Circ Res. 2007 Jul 6;101(1):59-68. Epub 2007 May 31.

7.

Angiogenesis: an organizing principle for drug discovery?

Folkman J.

Nat Rev Drug Discov. 2007 Apr;6(4):273-86. Review.

PMID:
17396134
8.

Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells.

Suárez Y, Fernández-Hernando C, Pober JS, Sessa WC.

Circ Res. 2007 Apr 27;100(8):1164-73. Epub 2007 Mar 22.

9.

Tomographic fluorescence imaging of tumor vascular volume in mice.

Montet X, Figueiredo JL, Alencar H, Ntziachristos V, Mahmood U, Weissleder R.

Radiology. 2007 Mar;242(3):751-8.

PMID:
17325064
10.

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P, Scadden DT, Benner T, Loeffler JS, Wen PY, Jain RK.

Cancer Cell. 2007 Jan;11(1):83-95.

11.

Molecular therapy in the microRNA era.

Wurdinger T, Costa FF.

Pharmacogenomics J. 2007 Oct;7(5):297-304. Epub 2006 Dec 26. Review.

PMID:
17189960
12.

miRNAs regulate miRNAs: coordinated transcriptional and post-transcriptional regulation.

Tuccoli A, Poliseno L, Rainaldi G.

Cell Cycle. 2006 Nov 1;5(21):2473-6. Epub 2006 Sep 19.

PMID:
17102639
13.

Epidermal growth factor receptor fate is controlled by Hrs tyrosine phosphorylation sites that regulate Hrs degradation.

Stern KA, Visser Smit GD, Place TL, Winistorfer S, Piper RC, Lill NL.

Mol Cell Biol. 2007 Feb;27(3):888-98. Epub 2006 Nov 13.

14.

MicroRNA signatures in human cancers.

Calin GA, Croce CM.

Nat Rev Cancer. 2006 Nov;6(11):857-66. Review.

PMID:
17060945
15.

The diverse functions of microRNAs in animal development and disease.

Kloosterman WP, Plasterk RH.

Dev Cell. 2006 Oct;11(4):441-50. Review.

16.

Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells.

Ewan LC, Jopling HM, Jia H, Mittar S, Bagherzadeh A, Howell GJ, Walker JH, Zachary IC, Ponnambalam S.

Traffic. 2006 Sep;7(9):1270-82.

PMID:
17004325
17.

A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes.

Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I.

Cell. 2006 Sep 22;126(6):1203-17.

18.

Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster.

Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, Thomas-Tikhonenko A.

Nat Genet. 2006 Sep;38(9):1060-5. Epub 2006 Jul 30.

19.

MicroRNAs modulate the angiogenic properties of HUVECs.

Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, Woods K, Mercatanti A, Hammond S, Rainaldi G.

Blood. 2006 Nov 1;108(9):3068-71. Epub 2006 Jul 18.

20.

Oncomirs - microRNAs with a role in cancer.

Esquela-Kerscher A, Slack FJ.

Nat Rev Cancer. 2006 Apr;6(4):259-69. Review.

PMID:
16557279

Supplemental Content

Support Center